4-甲基-喹啉-6-基胺 | 53867-94-0

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 喹啉及其衍生物
• 中文名称: 4-甲基-喹啉-6-基胺
• 英文名称: 4-methyl-quinolin-6-ylamine
• 英文别名: 4-methyl-[6]quinolylamine；4-Methyl-[6]chinolylamin；4-methyl-6-quinolinamine；6-Aminolepidin；4-methylquinolin-6-amine
• CAS: 53867-94-0
• 化学式: C₁₀H₁₀N₂
• 分子量: 158.203
• InChiKey: XBEXGDZXQLPQCV-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.9
• 重原子数：
  12
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.1
• 拓扑面积：
  38.9
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  4-甲基-喹啉-6-基胺 在 吡啶 、 间氯过氧苯甲酸 作用下， 以 乙醚 为溶剂， 反应 36.0h， 生成
  参考文献：
  名称：

  Hepatitis C NS5B polymerase inhibitors: Functional equivalents for the benzothiadiazine moiety

  摘要：

  A series of quinoline derivatives was synthesized as potential bioisosteric replacements for the benzothiadiazine moiety of earlier Hepatitis C NS5B polymerase inhibitors. Several of these compounds exhibited potent activity in enzymatic and replicon assays. (C) 2011 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2010.12.067
• 作为产物：
  描述：

  alkaline earth salt of/the/ methylsulfuric acid 在 ammonium chloride 、 氨 、 zinc(II) chloride 作用下， 生成 4-甲基-喹啉-6-基胺
  参考文献：
  名称：

  Busch; Koenigs, Chemische Berichte, 1890, vol. 23, p. 2687

  摘要：

  DOI：

文献信息

• 2, 6-Di-Nitrogen-Containing Substituted Purine Derivative, And Preparation Method, Pharmaceutical Composition And Use Thereof
  申请人：ZHEJIANG MEDICINE CO., LTD. XINCHANG PHARMACEUTICAL FACTORY

  公开号：US20160207924A1

  公开（公告）日：2016-07-21

  The present invention provides a 2, 6-di-nitrogen-containing substituted purine derivative having a formula (I) structure, or pharmaceutical salt or hydrate thereof, and preparation method and use thereof. The compound is broad spectrum anticancer, low toxicity, high anticancer activity and good stability.

  本发明提供了一种具有式（I）结构的2,6-二氮含量取代嘌呤衍生物，或其药用盐或水合物，以及其制备方法和用途。该化合物具有广谱抗癌、低毒性、高抗癌活性和良好稳定性。
• Method for optical measurement of multi-stranded nucleic acid
  申请人：Nakamura Kouki

  公开号：US20050112770A1

  公开（公告）日：2005-05-26

  A method for optical measurement of a multi-stranded nucleic acid which comprises the step of bringing a compound into contact with a multi-stranded nucleic acid wherein said compound is capable of interacting with the multi-stranded nucleic acid, wherein the compound has the following properties: (a) the compound can exist in a substantially colorless and non-fluorescent state under at least one condition in an aqueous solution in the absence of the multi-stranded nucleic acid, and (b) when the multi-stranded nucleic acid is allowed to exist in the condition defined in the above (a), the compound changes to a substantially colored state based on an interaction with the multi-stranded nucleic acid and substantially expresses fluorescent property based on said interaction.

  一种用于多股核酸的光学测量方法，包括以下步骤：将一种化合物与多股核酸接触，所述化合物能够与多股核酸相互作用，且该化合物具有以下性质：(a) 在无多股核酸的情况下，该化合物能够在水溶液中在至少一种条件下处于基本无色和非荧光状态，(b) 当多股核酸存在于上述(a)定义的状态下时，该化合物会因与多股核酸的相互作用而转变为基本上有色的状态，并基于该相互作用而表现出基本上荧光的性质。
• METHOD FOR OPTICAL MEASUREMENT OF MULTI-STRANDED NUCLEIC ACID
  申请人：NAKAMURA Kouki

  公开号：US20080124732A1

  公开（公告）日：2008-05-29

  A method for optical measurement of a multi-stranded nucleic acid which comprises the step of bringing a compound into contact with a multi-stranded nucleic acid wherein said compound is capable of interacting with the multi-stranded nucleic acid, wherein the compound has the following properties: (a) the compound can exist in a substantially colorless and non-fluorescent state under at least one condition in an aqueous solution in the absence of the multi-stranded nucleic acid, and (b) when the multi-stranded nucleic acid is allowed to exist in the condition defined in the above (a), the compound changes to a substantially colored state based on an interaction with the multi-stranded nucleic acid and substantially expresses fluorescent property based on said interaction.

  一种用于光学测量多股核酸的方法，包括以下步骤：将一种化合物与多股核酸接触，其中该化合物能够与多股核酸相互作用，该化合物具有以下特性：（a）在无多股核酸存在的情况下，在水溶液中至少有一个条件下，该化合物可以存在于基本无色且不发荧光的状态；（b）当多股核酸被允许在上述（a）所定义的条件下存在时，该化合物会因与多股核酸的相互作用而转变为基本上带色的状态，并基于该相互作用表现出基本上发荧光的特性。
• [EN] 2, 6-DI-NITROGEN-CONTAINING SUBSTITUTED PURINE DERIVATIVE, AND PREPARATION METHOD, PHARMACEUTICAL COMPOSITION AND USE THEREOF<br/>[FR] DÉRIVÉ DE PURINE SUBSTITUÉ CONTENANT DE L'AZOTE 2, 6-DI ET SON PROCÉDÉ DE PRÉPARATION, COMPOSITION PHARMACEUTIQUE ET UTILISATION DE CELLE-CI
  申请人：ZHEJIANG MED XINCHANG PHARM

  公开号：WO2015027667A1

  公开（公告）日：2015-03-05

  本发明提供了一种式(I)结构的2，6-二含氮取代的嘌呤衍生物或其药用盐或其水合物及其制备方法和其应用。本发明的化合物具有毒性低、抗癌谱广、抗癌活性高、稳定性好等特点。
• 10.1080/15421406.2024.2351732
  作者：Smokal, Vitaliy、Khomenko, Dmytro、Studzinsky, Sergey、Kutsevol, Nataliya、Lampeka, Rostyslav、Panova, Anna

  DOI：10.1080/15421406.2024.2351732

  日期：——

  The new methacrylic azomethine-containing monomers with side chain quinoline moiety were synthesized by reaction of their corresponding alcohols with methacryloyl chloride. The polymers based on ne...

  通过相应的醇与甲基丙烯酰氯反应合成了具有侧链喹啉结构的新型甲基丙烯酸含偶氮甲碱单体。基于新的聚合物...